mvjrМедицинский вестник Юга РоссииMedical Herald of the South of Russia2219-80752618-7876The Rostov State Medical University10.21886/2219-8075-2018-9-2-51-60mvjr-665Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESВлияние нейрогенной хронической боли на показатели калликреин-кининовой системы в коже самок мышей в динамике развития меланомы В16/F10Infl uence of neurogenic chronic pain on indicators of kallikreinkinin system in skin of female mice in dynamics of В16/F10 melanoma developmenthttps://orcid.org/0000-0003-3061-6108КитО. И.KitO. I.

Кит Олег Иванович, член-корр. РАН, д.м.н., профессор, генеральный директор.

Ростов-на-Дону.

Oleg I. Kit, corresponding member. RAS, Doctor of Medicine, Professor, General Director.

Rostov-on-Don.

onkosekretar@mail.ruhttps://orcid.org/0000-0002-3972-2452КотиеваИ. М.KotievaI. M.

Котиева Инга Мовлиевна, к.м.н., доцент кафедры патологической физиологии.

Ростов-на-Дону.

Inga M. Kotieva, PhD, Rostov State Medical University.

Rostov-on-Don.

https://orcid.org/0000-0003-3618-6890ФранциянцЕ. М.FrantsiyantsE. M.

Франциянц Елена Михайловна, д.б.н., профессор, заместитель генерального директора по науке.

Ростов-на-Дону.

Elena M. Frantsiyants, Doctor of Biological Sciences, Professor, Deputy Director General for Science.

Rostov-on-Don.

super.gormon@yandex.ruhttps://orcid.org/0000-0002-3972-2452КаплиеваИ. В.KaplievaI. V.

Каплиева Ирина Викторовна, к.м.н., старший научный сотрудник.

Ростов-на-Дону.

Irina V. Kaplieva, PhD.

Rostov-on-Don.

https://orcid.org/0000-0002-3907-0976КозловаЛ. С.KozlovaL. S.

Козлова Лариса Степановна, к.б.н., доцент, старший научный сотрудник.

Ростов-на-Дону.

Larisa S. Kozlova, PhD.

Rostov-on-Don.

https://orcid.org/0000-0002-2302-8271БандовкинаВ. А.BandovkinaV. A.

Бандовкина Валерия Ахтямовна, к.б.н., старший научный сотрудник.

Ростов-на-Дону.

Valeria A. Bandovkina, PhD.

Rostov-on-Don.

https://orcid.org/0000-0002-2674-9832ПогореловаЮ. А.PogorelovaYu. A.

Погорелова Юлия Александровна, к.б.н., старший научный сотрудник.

Ростов-на-Дону.

Yulia A. Pogorelova, PhD.

Rostov-on-Don.

https://orcid.org/0000-0002-3711-8155ЧеряринаН. Д.CheryarinaN. D.

Черярина Наталья Дмитриевна, врач лаборант.

Ростов-на-Дону.

Natalya D. Cheryarina, Rostov Research Institute of Oncology.

Rostov-on-Don.

БликянМ. В.BlikyanM. V.

Бликян Марина Владимировна, к.м.н., ассистент кафедры патологической физиологии.

Ростов-на-Дону.

Marina V. Blikyan, PhD.

Rostov-on-Don.

Ростовский научно-исследовательский онкологический институт.РоссияRostov Research Institute of Oncology.Russian FederationРостовский государственный медицинский университет.Russian FederationRostov State Medical University.Russian Federation201809062018925160Copyright © Кит О.И., Котиева И.М., Франциянц Е.М., Каплиева И.В., Козлова Л.С., Бандовкина В.А., Погорелова Ю.А., Черярина Н.Д., Бликян М.В., 20182018Кит О.И., Котиева И.М., Франциянц Е.М., Каплиева И.В., Козлова Л.С., Бандовкина В.А., Погорелова Ю.А., Черярина Н.Д., Бликян М.В.Kit O.I., Kotieva I.M., Frantsiyants E.M., Kaplieva I.V., Kozlova L.S., Bandovkina V.A., Pogorelova Y.A., Cheryarina N.D., Blikyan M.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.medicalherald.ru/jour/article/view/665меланомахроническая нейрогенная болькининовая системаmelanomachronic neurogenic painkinin system1Федеральное государственное бюджетное учреждение «Ростовский научно-исследовательский онкологический институт» Министерства здравоохранения Российской Федерации. Россия,ReferencesKuner R. Central mechanisms of pathological pain. // Nat Med. – 2010. – V.16(11). – P. 1258-1266. doi: 10.1038/nm.2231Kuner R. Central mechanisms of pathological pain.  Nat Med. 2010;16(11):1258-1266. doi: 10.1038/nm.2231Schweinhardt P., Bushnell M.C. Pain imaging in health and disease–how far have we come? // J Clin Invest. – 2010. – V.120(11). – P.3788-97. doi: 10.1172/JCI43498.Schweinhardt P, Bushnell MC. Pain imaging in health and disease–how far have we come?  J Clin Invest. 2010;120(11):3788-97. doi: 10.1172/JCI43498Falsetta M.L., Foster D.C., Woeller C.F., Pollock S.J., Bonham A.D., Haidaris C.G., Phipps R.P. A Role for Bradykinin Signaling in Chronic Vulvar Pain. // J Pain. – 2016. – V.17(11). – P.1183-1197. doi: 10,1016/j.jpain.2016.07.007Falsetta ML, Foster DC, Woeller CF, Pollock SJ, Bonham AD, et al. A Role for Bradykinin Signaling in Chronic Vulvar Pain. J Pain. 2016;17(11):1183-1197. doi: 10,1016/j.jpain.2016.07.007Maria A.G., Dillenburg-Pilla P., Reis R.I., Floriano E.M., TeféSilva C., Ramos S.G., Pesquero J.B., Nahmias C., Costa-Neto C.M. Host kinin B1 receptor plays a protective role against melanoma progression. // Sci Rep. – 2016. – V.6. – P.22078. doi: 10.1038/srep22078Maria AG, Dillenburg-Pilla P, Reis RI, Floriano EM, TeféSilva C, et al. Host kinin B1 receptor plays a protective role against melanoma progression. Sci Rep. 2016;6:22078. doi: 10.1038/srep22078Luiz A.P., Schroeder S.D., Rae G.A., Calixto J.B., Chichorro J.G. Th e contribution and interaction of kinin receptors and dinorphin A in the model of neuropathic pain of the trigeminal nerve in mice. // Neuroscience. – 2015. – V.300. – P. 189-200. doi: 10.1016/j.neuroscience.2015.05.015Luiz AP, Schroeder SD, Rae GA, Calixto JB, Chichorro JG. Th e contribution and interaction of kinin receptors and dinorphin A in the model of neuropathic pain of the trigeminal nerve in mice. Neuroscience. 2015;300:189-200. doi: 10.1016/j.neuroscience.2015.05.015Takeda M., Takehana S., Sekiguchi K., Kubota Y., Shimazu Y. Modulatory Mechanism of Nociceptive Neuronal Activity by Dietary Constituent Resveratrol. // Int J Mol Sci. – 2016. – V.17(10). – P.pii: E1702. doi: 10.3390/ijms17101702Takeda M, Takehana S, Sekiguchi K, Kubota Y, Shimazu Y. Modulatory Mechanism of Nociceptive Neuronal Activity by Dietary Constituent Resveratrol. Int J Mol Sci. 2016;17(10):pii:E1702. doi: 10.3390/ijms17101702Schmidt Bryan L., Hamamoto Darry T., Simone D., Wilcox George L. Mechanism of pain in cancer. // Mol Interv. – 2010. – V.10 (3). – P.164-178. doi: 10.1124/mi.10.3.7Schmidt Bryan L, Hamamoto Darry T, Simone D, Wilcox George L. Mechanism of pain in cancer. Mol Interv. 2010;10(3):164-178. doi: 10.1124/mi.10.3.7Yang F., Xu Q., Shu B., Tiwari V., He S.Q., Vera-Portocarrero L.P., et al. Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fi ber stimulation. // Pain. – 2016. – V.157(11). – P. 2582-2593. DOI: 10.1097/j.pain.0000000000000680Yang F, Xu Q, Shu B, Tiwari V, He SQ, et al. Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fi ber stimulation. Pain. 2016;157(11):25822593. doi: 10.1097/j.pain.0000000000000680Basso L., Altier C. Transient Receptor Potential Channels in neuropathic pain. // Curr Opin Pharmacol. – 2017. – V.32. – P.9-15. doi: 10.1016/j.coph.2016.10.002Basso L, Altier C. Transient Receptor Potential Channels in neuropathic pain. Curr Opin Pharmacol. 2017;32:9-15. doi: 10.1016/j.coph.2016.10.002Delaunay T., Deschamps L., Haddada M., Walker F., Soosaipillai A., et al. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion. // Mol Oncol. – 2017. – V.11(10). – P.1330-1347. doi: 10.1002/1878-0261.12103Delaunay T, Deschamps L, Haddada M, Walker F, Soosaipillai A, et al. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion. Mol Oncol. 2017;11(10):1330-1347. doi: 10.1002/1878-0261.12103Pavlopoulou A., Pampalakis G., Michalopoulos I., Sotiropoulou G. Evolutionary History of Tissue Kallikreins. // PLoS One. – 2010. – V.1(5). – P.e13781. doi: 10.1371/journal.pone.0013781Pavlopoulou A, Pampalakis G, Michalopoulos I, Sotiropoulou G. Evolutionary History of Tissue Kallikreins. PLoS One. 2010;5(11):e13781. doi: 10.1371/journal.pone.0013781Kryza T., Silva M.L., Loessner D., Heuzé-Vourc’h N., Clements J.A. Th e kallikrein-related peptidase family: Dysregulation and functions during cancer progression. // Biochimie. – 2016. – V.122. – P. 283-99. doi: 10.1016/j.biochi.2015.09.002Kryza T,  Silva ML,  Loessner D,  Heuzé-Vourc’h N,  Clements JA. Th e  kallikrein-related peptidase family: Dysregulation and functions during cancer progression. Biochimie. 2016;122:283-99. doi: 10.1016/j.biochi.2015.09.002Borgoño C.A., Michael I.P., Komatsu N., Jayakumar A., Kapadia R., et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. // J Biol Chem. – 2007. – V.282. – P.3640-52.Borgoño CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem. 2007;282:3640-52.Kontos C.K., Scorilas A. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. // Clin Chem Lab Med. – 2012. – V.50(11). – P. 1877-91. Doi: 10.1515/cclm-20120247Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Clin Chem Lab Med. 2012;50(11):1877-91. Doi: 10.1515/cclm-2012-0247Paterson C.J., Zambreanu L., Bennett D., McMahon S.B. Characteristics and mechanisms of pain caused by bradykinin, in humans using iontophoresis. // Pain. – 2013. – V.154(6). – P. 782-792. doi: 10.1016 / j.pain.2013.01.003Paterson CJ, Zambreanu L, Bennett D, McMahon SB. Characteristics and mechanisms of pain caused by bradykinin, in humans using iontophoresis. Pain. 2013;154(6):782-792. doi: 10.1016/j.pain.2013.01.003Koumandou V.L., Scorilas A. Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms. // PLoS One. – 2013. – V.8(7). – P.e68074. doi: 10.1371/journal. pone.0068074Koumandou VL, Scorilas A. Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms. PLoS One. 2013;8(7):e68074Avgeris M., Scorilas A. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies. // Expert Opin Th er Targets. – 2016. – V.20(7). – P.801-18. doi: 10.1517/14728222.2016.1147560Avgeris M, Scorilas A. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies. Expert Opin Th er Targets. 2016;20(7):80118. doi: 10.1517/14728222.2016.1147560Ferreira J., Campos M.M., Peshero J.B., Araujo R.K., Bader M., Calixto J. Evidence of the participation of kinins in Freundinduced adjuvant infl ammatory and nociceptive responses in mouse knockout mice of B1 and B2 kin. // Neuropharmacology. – 2001. – V. 41(8). – P. 1006-12.Ferreira J, Campos MM, Peshero JB, Araujo RK, Bader M, Calixto J. Evidence of the participation of kinins in Freundinduced adjuvant infl ammatory and nociceptive responses in mouse knockout mice of B1 and B2 kin. Neuropharmacology. 2001;41(8):1006-12.Werner M.F., Kassuya C.A., Ferreira J., Zampronio A.R., Calixto J.B., Rae G.A. Mechanisms controlled by peripheral kinin receptors B (1) and B (2) are involved in neuropathic nociception caused by ligation of the spinal nerve in rats. // Neuropharmacology. – 2007. – V.53(1). – P.48-57. doi: 10.1016/j.neuropharm.2007.04.013Werner MF, Kassuya CA, Ferreira J, Zampronio AR, Calixto JB, Rae GA. Mechanisms controlled by peripheral kinin receptors B (1) and B (2) are involved in neuropathic nociception caused by ligation of the spinal nerve in rats. Neuropharmacology. 2007;53(1):48-57. doi: 10.1016/j.neuropharm.2007.04.013Dillenburg-Pilla P., Maria A.G., Reis R.I., Floriano E.M., Pereira C., et al. Kinin B1 receptor activation enhances melanoma tumor growth and metastasis. // PLoS One. – 2013. – V. 8(5). – P.e64453. doi: 10.1371 / journal.pone.0064453Dillenburg-Pilla P, Maria AG, Reis RI, Floriano EM, Pereira C, et al. Kinin B1 receptor activation enhances melanoma tumor growth and metastasis. PLoS One. 2013;8(5):e64453. doi: 10.1371/journal.pone.0064453Dingemanе K.P. B-16 Melanoma Metastasis in Mouse Liver and Lung. // Inv. Metast. – 1985. – V.(5). – P.50-60.Dingemanе KP. B-16 Melanoma Metastasis in Mouse Liver and Lung. Inv. Metast. 1985;(5):50-60.Huang X., Player M.P. B1 Bradykinin receptor antagonists as potential therapeutic agents for pain. // J Med Chem. – 2010. – V.53. – P.5383-5389.Huang X, Player MP. B1 Bradykinin receptor antagonists as potential therapeutic agents for pain. J Med Chem. 2010;53:5383-5389.Costa R., Motta E.M., Dutra R.C., Magnavaci M.N., Bento A. F., et al. Antinociceptive action of kinase receptor antagonists B 1 and B 2 on peripheral neuropathy induced by paclitaxel in mice. // Br J Pharmacol. – 2011. – V.164 (2b). – P.681-693. doi: 10.1111/j.1476-5381.2011.01408.xCosta R, Motta EM, Dutra RC, Magnavaci MN, Bento AF, et al. Antinociceptive action of kinase receptor antagonists B 1 and B 2 on peripheral neuropathy induced by paclitaxel in mice. Br J Pharmacol. 2011;164(2b):681-693. doi: 10.1111/j.1476-5381.2011.01408.xTang S.C., Leung J.C., Lai K.N. Th e kallikrein-kinin system. // Contribution of Nephrole. – 2011. – V.170. – P.145-55. doi: 10.1159/000325650Tang SC, Leung JC, Lai KN. Th e kallikrein-kinin system. Contribution of Nephrole. 2011;170:145-55. doi: 10.1159/000325650Balkwill F., Mantovani A. Infl ammation and cancer: back to Virchow? // Lancet. – 2001. – V.(17). – P.539-545 doi: 10.1016/S0140-6736(00)04046-0Balkwill F, Mantovani A. Infl ammation and cancer: back to Virchow?  Lancet.  2001;(17):539-545. doi: 10.1016/S01406736(00)04046-0Hanahan D., Weinberg R. A. Hallmarks of cancer: the next generation. // Cell. – 2011. – V.144. – P.646-674. doi: 10.1016/j.cell.2011.02.013Hanahan D, Weinberg RA.  Hallmarks of cancer: the next generation.  Cell.  2011;144:646-674. doi: 10.1016/j.cell.2011.02.013Lizama A.J., Andrade Y., Colivoro P., Sarmiento J., Matus C.E., et al. Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil. // Innate Immun. – 2015. – V.21(6). – P.575-86. doi: 10.1177/1753425914566083Lizama AJ, Andrade Y, Colivoro P, Sarmiento J, Matus CE, et al. Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil. Innate Immun. 2015;21(6):575-86. doi: 10.1177/1753425914566083Pampalakis G., Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. // Biochim Biophys Acta. – 2007. – V.1776(1). – P.22-31. doi: 10.1016/j.bbcan.2007.06.001Pampalakis G, Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta. 2007;1776(1):22-31. doi: 10.1016/j.bbcan.2007.06.001Ehrenfeld P., Manso L., Pavicic M.F., Matus C.E., Borquez C., et al. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B1 receptor in breast cancer cells. // Anticancer Res. – 2014. – V.34(12). – P. 6925-38.Ehrenfeld P, Manso L, Pavicic MF, Matus CE, Borquez C, et al. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B1 receptor in breast cancer cells. Anticancer Res. 2014;34(12):6925-38.Menashi S., Fridman R., Desrivieres S., Lu H., Legrand Y., Soria C. Regulation of 92-kDa gelatinase B activity in the extracellular matrix by tissue kallikrein. // Ann N Y Acad Sci. – 1994. – V.732(6). – P. 466-8.Menashi S,  Fridman R,  Desrivieres S,  Lu H,  Legrand Y, Soria C. Regulation of 92-kDa gelatinase B activity in the extracellular matrix by tissue kallikrein. Ann N Y Acad Sci. 1994;732(6):466-8

The authors declare that there are no conflicts of interest present.